Sodium bicarbonate administration in adult in-hospital cardiac arrest: propensity-score-weighted associations with sustained ROSC, 30-day survival and neurological outcomes

Sodium bicarbonate (SB) is frequently administered during resuscitation for in-hospital cardiac arrest (IHCA), although supporting evidence for its clinical effectiveness is limited. This study aimed to evaluate the association between SB administration and clinical outcomes in IHCA patients. We retrospectively analyzed adult patients with non-traumatic IHCA across three tertiary hospitals from January 2019 to December 2022. Propensity score-based approaches, prespecified subgroup analyses, weighted logistic regression models were used to assess the outcomes (30-d survival, sustained ROSC and favorable neurological outcome). Among 2,461 IHCA patients, 945 (38.4%) received SB. Before propensity score weighting, compared to non-SB group, the SB group had lower 30-day survival (6.2% vs. 9.4%; OR 0.64 [95% CI, 0.46–0.87]) and favorable neurological outcome (2.1% vs. 5.0%; OR 0.41 [95% CI, 0.24–0.67]), but higher sustained ROSC (34.3% vs. 30.5%; OR 1.19 [95% CI, 1.01–1.42]). After weighting, 30-day survival was comparable between groups (7.5% vs. 7.8%; OR 0.96 [95% CI, 0.66–1.39]), sustained ROSC remained higher in the SB group (44.4% vs. 27.3%; OR 2.12 [95% CI, 1.73–2.60]), and favorable neurological outcome showed no significant difference (2.6% vs. 4.1%; OR 0.62 [95% CI, 0.33–1.17]). Subgroup analyses indicated that SB improved sustained ROSC in patients with cardiopulmonary resuscitation (CPR) duration < 60 min, arrest occurring in ICU/general wards, respiratory/neurological/suspected cardiac causes, non-shockable rhythms, and without calcium administration. Conversely, CPR duration < 20 min, airway interventions, and non-antiarrhythmics administration were associated with worse neurological outcomes. SB administration during CPR in IHCA patients did not improve 30-d survival or neurological outcomes, despite being associated with higher rates of sustained ROSC. Routine SB use during CPR is not supported; improving post-resuscitation management may help translate the short-term benefit of facilitating sustained ROSC into long-term gains.

Authors

Institutions

Publication Details

Journal
BMC Emergency Medicine
Published
2026-11-13
DOI
https://doi.org/10.1186/s12873-026-01853-9
Primary Topic
Cardiac Arrest and Resuscitation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Sodium bicarbonate administration in adult in-hospital cardiac arrest: propensity-score-weighted associations with sustained ROSC, 30-day survival and neurological outcomes

Zhao Yang, Yixiao Xu, Xiaotong Han, Yuanyuan Zhang et al.
2 links
BMC Emergency Medicine
Cardiac Arrest and Resuscitation
article

Sodium bicarbonate administration in adult in-hospital cardiac arrest: propensity-score-weighted associations with sustained ROSC, 30-day survival and neurological outcomes

Zhao Yang, Yixiao Xu, Xiaotong Han, Yuanyuan Zhang, Lei Wang, Qiqi Luo, Lianhong Zou, Niandan Hu, Qiyang Liang
article en

Abstract

Sodium bicarbonate (SB) is frequently administered during resuscitation for in-hospital cardiac arrest (IHCA), although supporting evidence for its clinical effectiveness is limited. This study aimed to evaluate the association between SB administration and clinical outcomes in IHCA patients. We retrospectively analyzed adult patients with non-traumatic IHCA across three tertiary hospitals from January 2019 to December 2022. Propensity score-based approaches, prespecified subgroup analyses, weighted logistic regression models were used to assess the outcomes (30-d survival, sustained ROSC and favorable neurological outcome). Among 2,461 IHCA patients, 945 (38.4%) received SB. Before propensity score weighting, compared to non-SB group, the SB group had lower 30-day survival (6.2% vs. 9.4%; OR 0.64 [95% CI, 0.46–0.87]) and favorable neurological outcome (2.1% vs. 5.0%; OR 0.41 [95% CI, 0.24–0.67]), but higher sustained ROSC (34.3% vs. 30.5%; OR 1.19 [95% CI, 1.01–1.42]). After weighting, 30-day survival was comparable between groups (7.5% vs. 7.8%; OR 0.96 [95% CI, 0.66–1.39]), sustained ROSC remained higher in the SB group (44.4% vs. 27.3%; OR 2.12 [95% CI, 1.73–2.60]), and favorable neurological outcome showed no significant difference (2.6% vs. 4.1%; OR 0.62 [95% CI, 0.33–1.17]). Subgroup analyses indicated that SB improved sustained ROSC in patients with cardiopulmonary resuscitation (CPR) duration < 60 min, arrest occurring in ICU/general wards, respiratory/neurological/suspected cardiac causes, non-shockable rhythms, and without calcium administration. Conversely, CPR duration < 20 min, airway interventions, and non-antiarrhythmics administration were associated with worse neurological outcomes. SB administration during CPR in IHCA patients did not improve 30-d survival or neurological outcomes, despite being associated with higher rates of sustained ROSC. Routine SB use during CPR is not supported; improving post-resuscitation management may help translate the short-term benefit of facilitating sustained ROSC into long-term gains.

BMC Emergency Medicine
Hunan Normal University (CN), Wuhan University (CN), Qianjiang Central Hospital (CN), Renmin Hospital of Wuhan University (CN), Hunan Provincial People's Hospital (CN)
Natural Science Foundation of Hunan Province
Good health and well-being
Cardiac Arrest and Resuscitation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon